Society of Nuclear Medicine and Molecular Imaging (SNMMI) | Strategic Alliance Partners
Latest from Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Establishing guideline harmonization and practice standardization may help promote the safe and consistent delivery of radiopharmaceutical therapies.
89Zr-DFO-daratumumab shows activity in identifying and localizing multiple myeloma, even in FDG-non-avid cases, per new phase 2 data.
Advertisement
Advertisement
Trending on CancerNetwork
1
Does Patient Selection Inflate CAR T Outcomes in Multiple Myeloma?
2
Changing Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer
3
Why CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma
4
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
5